We offer a full suite of interim management, consulting, advisory and business/corporate development services to organizations with an interest in the life science sector. Recent engagements include/included:

​

• developing innovation strategy for a mid-sized public medical cannabis company;

• acting as VP, Business Development for a private start-up protein engineering/immuno-oncology company;

• identifying late-stage in-licensing opportunities for a mid-sized public specialty pharma company;

• serving as start-up CEO to an academic spin-out women's health therapeutics company. 

We look forward to learning about your needs and building a relationship.

Robert Foldes has spent his entire 25+ year career in the life science sector. He has worked with start-up, emerging and large biotechnology firms, specialty pharmaceutical companies, medical cannabis companies, and leading teaching hospitals & research institutes. He provides a unique perspective that bridges industry and academia, business and science. Robert has consulted for organizations with an interest in the life science sector since 2005. 

In his career, Robert has served as CEO of Cytochroma Inc., and Viteava Pharmaceuticals Inc. and held senior business development roles at The Hospital for Sick Children and Allelix Biopharmaceuticals Inc. He holds a PhD in Pharmacology from the University of Nebraska Medical Center and an MBA from the Schulich School of Business. He resides in Toronto, Canada.

• Strategic planning, innovation strategy

• Opportunity identification & assessment

• Due diligence, competitive intelligence

• In-licensing & out-licensing

• Business plans, investor presentations

• Intellectual property management

• Preclinical drug development 

• Managing R&D collaborations and CROs

• Project management

• Drafting patent applications

• Financing strategy

• Medical/scientific writing including SR&ED claim submissions and grant writing